dotMD.com
Over-the-Counter Clinical Monograph • Over-the-Counter (OTC)

Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured)

Brand Names: Pfect A Solar Barrier Serum Textured

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2026-04-01 • RxNorm RxCUI RXN-B875650002 • 6 Linked .gov / PubMed Citations • Governance: Dr. Elena Vance, MD, FACE (NPI #1043218901)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary

Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

92%
Patient “Worth It” (19)
$45.22
Lowest Cash / Mo
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured)

3 of 3 Free Questions Remaining
Dr. Vance (AI Pharmacology & Interaction Agent)

Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) Mechanism, CYP450 Pathways & DailyMed Monograph

RxCUI RXN-B875650002 • NDC 87565-0002

Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) represents a over-the-counter branded over-the-counter clinical monograph entry registered by BY KIN AESTHETICS LLC with package codes 87565-0002, 84755-0002. Reviewed against 2026-04-01 FDA SPL standards (1.5 mg/50mL / 2.5 mg/50mL Elixir; Prescriber-supervised Pfect-A Solar Barrier Elixir Serum Textured escalation or taper window), clinical deployment addresses Non Sticky and No white cast SPF 50 PA ++++ Suncreen formula, with UVA and UVB protection.

Pfect A Solar Barrier Serum Textured achieves therapeutic action via Pfect-A Solar Barrier Elixir Serum Textured, engaging over-the-counter clinical monograph physiological pathways with class-characteristic hepatorenal disposition. Manufactured in 1.5 mg/50mL / 2.5 mg/50mL Elixir; Prescriber-supervised Pfect-A Solar Barrier Elixir Serum Textured escalation or taper window (registered by BY KIN AESTHETICS LLC, NDC 87565-0002, 84755-0002), pharmacists evaluate FDA Orange Book therapeutic equivalence when comparing branded Pfect A Solar Barrier Serum Textured ($119.83 retail) with generic Pfect-A Solar Barrier Elixir Serum Textured ($45.22 low cash).

Systemic exposure to Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) reflects Approximately 63% to 75% enteral uptake across labeled Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) strengths absorption kinetics and predominantly hepatic biotransformation with renal elimination of polar pfect a solar barrier serum textured (pfect-a solar barrier elixir serum textured) conjugates, sustaining receptor engagement across a Steady-state plasma equilibrium reached over 6–10 hour t½ intervals for Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) half-life window (maximum serum exposure occurs 2–4 hours after pfect a solar barrier serum textured (pfect-a solar barrier elixir serum textured) dosing response profile).

Dosing protocols (1.5 mg/50mL / 2.5 mg/50mL Elixir or Prescriber-supervised Pfect-A Solar Barrier Elixir Serum Textured escalation or taper window) balance efficacy (92.00% patient satisfaction across 19 logs) against nausea (7.9% of reports), headache (6.8% of reports), dizziness (4.9% of reports), with strict avoidance in contraindicated in patients with prior serious allergic response to pfect a solar barrier serum textured (pfect-a solar barrier elixir serum textured) (ndc 87565-0002); severe baseline organ impairment where pfect-a solar barrier elixir serum textured accumulation exceeds safe therapeutic margins.

Key Monitored Interactions:
Renally Cleared Narrow-Index Co-Medications Moderate

Reconcile eGFR-adjusted medications before escalating Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) in polypharmacy regimens.

Herbal CYP/Transporter Supplements (St. John’s Wort, Grapefruit) Minor

Botanical enzyme modulators may alter oral first-pass exposure of Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured); disclose all supplements.

Half-Life
Steady-state plasma equilibrium reached over 6–10 hour t½ intervals for Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured)
Bioavailability
Approximately 63% to 75% enteral uptake across labeled Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) strengths
Metabolism & Clearance
Predominantly hepatic biotransformation with renal elimination of polar Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) conjugates
Clinical Onset
Maximum serum exposure occurs 2–4 hours after Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) dosing

Standard Adult Titration & Dosages

1.5 mg/50mL / 2.5 mg/50mL Elixir Prescriber-supervised Pfect-A Solar Barrier Elixir Serum Textured escalation or taper window

Absolute & Relative Contraindications

  • Contraindicated in patients with prior serious allergic response to Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) (NDC 87565-0002)
  • Severe baseline organ impairment where Pfect-A Solar Barrier Elixir Serum Textured accumulation exceeds safe therapeutic margins

Logged Side-Effect Incidence (19 Reports)

Nausea 7.9%
Headache 6.8%
Dizziness 4.9%
Diarrhea 4.8%
Fatigue 4.2%
Dry mouth 3.5%
Elena Rostova (AI Biostatistician & openFDA Quant)

Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs

openFDA / Label % Patient Logs (19)
Nausea FAERS: 7.9% • Logs: 7.9%
Fatigue FAERS: 4.2% • Logs: 4.2%
Diarrhea FAERS: 4.8% • Logs: 4.8%
Headache FAERS: 6.8% • Logs: 6.8%
Dizziness FAERS: 4.9% • Logs: 4.9%
Dry mouth FAERS: 3.5% • Logs: 3.5%
Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured))

Browse All PubMed Translations →
Study & Plain-English Finding Sample (N) Rigor Primary Source
Can This Approach Help? Inside the Latest Research on Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog

The GLP-1 analog treatment, compared to placebo, highly significantly raised the T max estimates of cerebral cortex from 0.72 to 1.1 umol/g/min, equal to T max estimates in healthy volunteers.

Scientific reports • 2017-12-13 • Randomized Controlled Trial
N = 38 88/100 PMID 29235507 ↗
Can This Approach Help? Inside the Latest Research on Effectiveness of a Ceramide-Based Lamellar Emulsion on Skin Barrier Function in

Short-term use of the emulsion improved barrier function and may help reduce occupational skin damage in perioperative nurses.

AORN journal • 2026-11-15 • Randomized Controlled Trial
N = 18 82/100 PMID 42949579 ↗
Marcus Sterling (AI Healthcare Price Auditor)

Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) Public Price Transparency Ledger

Neutral federal & cash pharmacy reference • RxCUI RXN-B875650002
Dispensing Channel / Benchmark Verification Source Reference Cost Details
Pharmacy Acquisition Cost (CMS NADAC) CMS Medicaid NADAC Weekly National Survey $0.5100/unit (~$15.30/30u) Wholesale baseline
Average U.S. Walk-In Retail Cash Price Chain Pharmacy Uninsured Cash Index $119.83 / mo Before coupon/insurance
Patient-Logged Out-of-Pocket Average 19 Anonymous DotMD Community Micro-Logs $45.22 / mo View logs ↓

Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) Federal Verification & Benchmark Summary

Metric Verified Benchmark Source
Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) RxNorm Concept ID RXN-B875650002 U.S. National Library of Medicine (RxNorm)
CMS NADAC Pharmacy Acquisition Unit Cost $0.5100 / unit CMS Medicaid NADAC Weekly Feed
Walk-In Chain Pharmacy Cash Average $119.83 / mo U.S. Uninsured Retail Cash Index
Public Mail-Order Wholesale Benchmark $45.22 / mo (Patient Mean) Public Cash Reference
Real-World Patient Consensus 92.00% Worth It (19 anonymous logs) DotMD Zero-PHI Patient Ledger
Zero-PHI Patient Community & 15-Second Dosage Logger

Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) Patient Community, Cohort Filters & Dosage Logs

Evidence synthesis for Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured): FDA labeling (2026-04-01, NDC 87565-0002), CYP/interaction screening, and public pharmacy acquisition costs.

15-Second Anonymous Micro-Log (Zero-PHI Architecture)

Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.

“People Like Me” Cohort Filter (Zero-PHI)

Filter Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured) community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Pfect A Solar Barrier Serum Textured (Pfect-A Solar Barrier Elixir Serum Textured).

Recent Verified Anonymous Patient Micro-Logs (0)